Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription


1 Acta Neurol Scand
3 BMC Neurol
1 Brain
2 Cephalalgia
2 Headache
2 Lancet Neurol

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Acta Neurol Scand

  1. VELASQUEZ-RIMACHI V, Chachaima-Mar J, Cardenas-Baltazar EC, Loayza-Vidalon A, et al
    Greater occipital nerve block for chronic migraine patients: A meta-analysis.
    Acta Neurol Scand. 2022 Jun 21. doi: 10.1111/ane.13634.
    PubMed         Abstract available

    BMC Neurol

  2. SOLEIMANIAN-BOROUJENI F, Badihian N, Badihian S, Shaygannejad V, et al
    The efficacy of transdiagnostic cognitive behavioral therapy on migraine headache: a pilot, feasibility study.
    BMC Neurol. 2022;22:230.
    PubMed         Abstract available

  3. RANJBAR M, Badihian N, Yazdi M, Milani S, et al
    "Incidence, characteristics and prognosis of cervical artery dissection-induced ischemic stroke in central Iran".
    BMC Neurol. 2022;22:227.
    PubMed         Abstract available

  4. ALSAADI T, Noori S, Varakian R, Youssef S, et al
    Real-world experience of erenumab in patients with chronic or episodic migraine in the UAE.
    BMC Neurol. 2022;22:221.
    PubMed         Abstract available


  5. MITCHELL BL, Diaz-Torres S, Bivol S, Cuellar-Partida G, et al
    Elucidating the relationship between migraine risk and brain structure using genetic data.
    Brain. 2022 Jun 23. pii: 6609984. doi: 10.1093.
    PubMed         Abstract available


  6. BRANDT RB, Cnossen VM, Doesborg PG, Coo IF, et al
    Unilateral increased visual sensitivity in cluster headache: a cross-sectional study.
    Cephalalgia. 2022;42:722-729.
    PubMed         Abstract available

  7. ZHOU Y, Zhang F, Starcevic Manning M, Hu Z, et al
    Immunogenicity of erenumab: A pooled analysis of six placebo-controlled trials with long-term extensions.
    Cephalalgia. 2022;42:749-760.
    PubMed         Abstract available


  8. TEPPER SJ, Grosberg B, Daniel O, Kuruvilla DE, et al
    Migraine treatment with external concurrent occipital and trigeminal neurostimulation-A randomized controlled trial.
    Headache. 2022 Jun 24. doi: 10.1111/head.14350.
    PubMed         Abstract available

    Headache associated with COVID-19: Epidemiology, characteristics, pathophysiology, and management.
    Headache. 2022;62:650-656.
    PubMed         Abstract available

    Lancet Neurol

  10. ASHINA M, Lanteri-Minet M, Pozo-Rosich P, Ettrup A, et al
    Safety and efficacy of eptinezumab for migraine prevention in patients with two-to-four previous preventive treatment failures (DELIVER): a multi-arm, randomised, double-blind, placebo-controlled, phase 3b trial.
    Lancet Neurol. 2022;21:597-607.
    PubMed         Abstract available

  11. ORNELLO R, Sacco S
    A new option for patients with treatment-resistant migraine.
    Lancet Neurol. 2022;21:578-579.

Thank you for your interest in scientific medicine.

AMEDEO Migraine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.